Physician profile

David L Jones

Obstetrics & Gynecology · Deridder, LA

NPI 1114924826

$196.98

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$140.26

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Hologic Sales and Service, LLC $60.87 2023 Coolseal Generator
Astellas Pharma US INC $38.46 2023-2024 Veozah
Pfizer INC. $26.04 2019
Ethicon US, LLC $24.74 2023 Enseal
Organogenesis INC. $18.86 2021
Mayne Pharma Commercial LLC $16.19 2023
Bolder Surgical, LLC $11.82 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David L Jones

$196.98

in general payments reported 2019-2025

Years
2019-2024
Top company
Hologic Sales and Service, LLC

https://glasscript.com/doctor/708830/david-l-jones

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.